HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming You Selected Research

4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)

1/2020Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I.
1/2013Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.
6/2006p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming You Research Topics

Disease

118Neoplasms (Cancer)
05/2022 - 04/2002
61Lung Neoplasms (Lung Cancer)
05/2022 - 10/2002
51Carcinogenesis
05/2022 - 06/2002
14Adenoma (Adenomas)
10/2019 - 06/2002
14Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019 - 03/2002
14Adenocarcinoma of Lung
10/2019 - 03/2002
12Adenocarcinoma
09/2017 - 04/2002
8Breast Neoplasms (Breast Cancer)
06/2020 - 02/2003
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 12/2006
7Urinary Bladder Neoplasms (Bladder Cancer)
02/2014 - 09/2004
7Body Weight (Weight, Body)
01/2013 - 02/2003
6Neoplasm Metastasis (Metastasis)
01/2020 - 05/2012
4Acute Lung Injury
09/2013 - 07/2010
3Mouth Neoplasms (Oral Cancer)
01/2021 - 01/2013
3Sepsis (Septicemia)
12/2017 - 07/2010
3Carcinoma (Carcinomatosis)
02/2014 - 06/2002
2Hypercholesterolemia
10/2019 - 02/2011
2Hypertriglyceridemia
10/2019 - 02/2011
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2017 - 08/2015
2Prostatic Neoplasms (Prostate Cancer)
11/2016 - 03/2009
2Inflammation (Inflammations)
05/2015 - 12/2004
2Lung Injury
09/2013 - 08/2012

Drug/Important Bio-Agent (IBA)

25CarcinogensIBA
01/2021 - 11/2002
19Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2003
12RNA (Ribonucleic Acid)IBA
05/2022 - 09/2004
12Biomarkers (Surrogate Marker)IBA
10/2020 - 01/2003
12Benzo(a)pyreneIBA
06/2015 - 05/2004
9Messenger RNA (mRNA)IBA
01/2019 - 01/2003
8MicroRNAs (MicroRNA)IBA
01/2021 - 02/2012
8DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2002
6honokiolIBA
05/2022 - 11/2014
6ErbB Receptors (EGF Receptor)IBA
01/2019 - 12/2006
6TeaIBA
01/2014 - 02/2006
6Urethane (Ethyl Carbamate)IBA
09/2012 - 11/2003
6polyphenon EIBA
06/2010 - 01/2006
6Codon (Codons)IBA
01/2010 - 02/2003
6SmokeIBA
01/2007 - 02/2003
5VaccinesIBA
12/2021 - 11/2016
5AerosolsIBA
01/2021 - 05/2007
5Bexarotene (LGD1069)FDA Link
10/2019 - 12/2009
5Budesonide (Pulmicort)FDA LinkGeneric
04/2019 - 08/2003
5Phosphotransferases (Kinase)IBA
01/2019 - 07/2006
5Gefitinib (Iressa)FDA Link
09/2017 - 12/2006
5Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
11/2013 - 02/2003
5OligonucleotidesIBA
07/2006 - 02/2004
4Biological ProductsIBA
06/2020 - 11/2007
4Pioglitazone (Actos)FDA Link
07/2017 - 11/2010
4LigandsIBA
01/2017 - 11/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 11/2003
4Amino AcidsFDA Link
08/2012 - 06/2003
3Pharmaceutical PreparationsIBA
01/2022 - 09/2010
34-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
01/2020 - 06/2006
3Estrogen ReceptorsIBA
12/2019 - 02/2003
3GlucocorticoidsIBA
04/2019 - 10/2004
3Antitumor BIBA
08/2015 - 05/2004
3Caspase 3 (Caspase-3)IBA
06/2015 - 05/2012
3Sirolimus (Rapamycin)FDA Link
04/2015 - 01/2006
3NitrosaminesIBA
02/2014 - 09/2004
3hydroxide ionIBA
02/2014 - 05/2011
3vinyl carbamateIBA
09/2013 - 11/2002
3Retinoid X Receptors (Retinoid X Receptor)IBA
03/2013 - 12/2009
270-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
05/2022 - 01/2019
2lonidamineIBA
05/2022 - 01/2019
2Atovaquone (Mepron)FDA Link
01/2022 - 01/2022
2Protein Subunit VaccinesIBA
01/2021 - 10/2017
2Immune Checkpoint ProteinsIBA
01/2021 - 10/2020
2Small Cytoplasmic RNAIBA
01/2021 - 10/2020
2AntigensIBA
10/2020 - 11/2019
2Superoxides (Superoxide)IBA
01/2020 - 01/2020
2PeroxiredoxinsIBA
01/2020 - 01/2019
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2020 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 01/2019
2CholesterolIBA
11/2019 - 02/2011
2Peptides (Polypeptides)IBA
11/2019 - 11/2016
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2019 - 05/2011
2CurcuminIBA
12/2017 - 10/2016
2AntibodiesIBA
02/2017 - 05/2005
2Tyrosine Kinase InhibitorsIBA
05/2016 - 05/2007
2NucleotidesIBA
02/2014 - 03/2004
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2014 - 01/2013
2Eflornithine (Ornidyl)FDA Link
02/2014 - 08/2008
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2014 - 09/2010
2Aromatase InhibitorsIBA
11/2013 - 01/2013
2vorozoleIBA
11/2013 - 01/2013
2Drinking WaterIBA
09/2013 - 01/2006
2Triglycerides (Triacylglycerol)IBA
03/2013 - 02/2011
2GinsenosidesIBA
03/2013 - 08/2012
2Selective Estrogen Receptor Modulators (SERM)IBA
01/2013 - 02/2003
2Butylated Hydroxytoluene (BHT)IBA
12/2012 - 01/2010
2MethylcholanthreneIBA
12/2012 - 01/2010
2ChlorineIBA
08/2012 - 07/2010
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2011 - 11/2010
2Transcription Factors (Transcription Factor)IBA
09/2010 - 09/2004
2Complex MixturesIBA
06/2009 - 02/2003
2TOR Serine-Threonine KinasesIBA
12/2007 - 01/2006

Therapy/Procedure

30Chemoprevention
05/2022 - 06/2002
22Therapeutics
01/2021 - 04/2004
5Immunotherapy
01/2022 - 01/2016
4Drug Therapy (Chemotherapy)
11/2016 - 12/2006
2Oral Administration
08/2012 - 12/2005